Ring Therapeutics Unveils Cutting-Edge Gene Therapy Platforms at ASGCT 2026 Conference#USA#Cambridge#gene_therapy#ASGCT_2026#Ring_Therapeutics
Ring Therapeutics Unveils Cutting-Edge Gene Therapy Platforms at ASGCT 2026 Conference
Ring Therapeutics has introduced groundbreaking technologies, Vector Conjugate and VectorBricks™ platforms, at the ASGCT 2026 conference, showcasing their potential for gene therapy advancements.
third-news.com
May 14, 2026 at 10:18 AM
Ring Therapeutics Unveils Cutting-Edge Gene Therapy Platforms at ASGCT 2026 Conference#USA#Cambridge#gene_therapy#ASGCT_2026#Ring_Therapeutics
Factor Bioscience to Present Groundbreaking Gene Therapy Research at ASGCT Annual Meeting#United_States#Boston#gene_therapy#Factor_Bioscience#ASGCT_2026
Factor Bioscience to Present Groundbreaking Gene Therapy Research at ASGCT Annual Meeting
Factor Bioscience is set to make a splash at the upcoming ASGCT Annual Meeting with seven presentations showcasing cutting-edge gene and cell therapies.
third-news.com
May 5, 2026 at 8:31 PM
Factor Bioscience to Present Groundbreaking Gene Therapy Research at ASGCT Annual Meeting#United_States#Boston#gene_therapy#Factor_Bioscience#ASGCT_2026
Mana.bio Expands Leadership Team and Prepares for ASGCT 2026 Presentation on AI-Driven RNA Delivery Innovations#Israel#Tel_Aviv#RNA_Delivery#Mana.bio#ASGCT_2026
Mana.bio Expands Leadership Team and Prepares for ASGCT 2026 Presentation on AI-Driven RNA Delivery Innovations
Mana.bio is set to unveil new AI-driven RNA delivery advancements at ASGCT 2026 while expanding its leadership team with industry veterans.
third-news.com
May 5, 2026 at 12:42 PM
Mana.bio Expands Leadership Team and Prepares for ASGCT 2026 Presentation on AI-Driven RNA Delivery Innovations#Israel#Tel_Aviv#RNA_Delivery#Mana.bio#ASGCT_2026